HYDROmorphone 20 mg/100 mL Injectable Solution — Class II drug recall D-1251-2019
Terminated recall by Advanced Pharma Inc., reported 2019-05-08, distributed nationwide. Sub-potency
| Recall number | D-1251-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Advanced Pharma Inc., Houston, TX, United States |
| Recall initiated | 2019-04-26 |
| Classified | 2019-04-29 |
| Reported by FDA | 2019-05-08 |
| Terminated | 2019-10-30 |
| Distributed | Nationwide (US) |
| Quantity | 560 bags |
| Reason classes | potency |
| NDC | 42852-0221-10 |
| Lot numbers | 0215, 22110P |
| Expiration dates | 2019-04-29 |
Product
HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, Sterile single use bag, Compounded Drug, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC: 42852-221-10
Reason for recall
Sub-potency
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1251-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.